Literature DB >> 20351140

Gamma interferon produced by antigen-specific CD4+ T cells regulates the mucosal immune responses to Citrobacter rodentium infection.

Hideyuki Shiomi1, Atsuhiro Masuda, Shin Nishiumi, Masayuki Nishida, Tetsuya Takagawa, Yuuki Shiomi, Hiromu Kutsumi, Richard S Blumberg, Takeshi Azuma, Masaru Yoshida.   

Abstract

Citrobacter rodentium, a murine model pathogen for enteropathogenic Escherichia coli, colonizes the surface of intestinal epithelial cells and causes mucosal inflammation. This bacterium is an ideal model for investigating pathogen-host immune interactions in the gut. It is well known that gene transcripts for Th1 cytokines are highly induced in colonic tissue from mice infected with C. rodentium. However, it remains to be seen whether the Th1 or Th2 cytokines produced by antigen-specific CD4(+) T cells provide effective regulation of the host immune defense against C. rodentium infection. To investigate the antigen-specific immune responses, C. rodentium expressing ovalbumin (OVA-C. rodentium), a model antigen, was generated and used to define antigen-specific responses under gamma interferon (IFN-gamma)-deficient or interleukin-4 (IL-4)-deficient conditions in vivo. The activation of antigen-specific CD4(+) T cells and macrophage phagocytosis were evaluated in the presence of IFN-gamma or IL-4 in vitro. IFN-gamma-deficient mice exhibited a loss of body weight and a higher bacterial concentration in feces during OVA-C. rodentium infection than C57BL/6 (wild type) or IL-4-deficient mice. This occurred through the decreased efficiency of macrophage phagocytosis and the activation of antigen-specific CD4(+) T cells. Furthermore, a deficiency in antigen-specific CD4(+) T-cell-expressed IFN-gamma led to a higher susceptibility to mucosal and gut-derived systemic OVA-C. rodentium infection. These results show that the IFN-gamma produced by antigen-specific CD4(+) T cells plays an important role in the defense against C. rodentium.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20351140      PMCID: PMC2876554          DOI: 10.1128/IAI.01343-09

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria.

Authors:  Masaru Yoshida; Kanna Kobayashi; Timothy T Kuo; Lynn Bry; Jonathan N Glickman; Steven M Claypool; Arthur Kaser; Takashi Nagaishi; Darren E Higgins; Emiko Mizoguchi; Yoshio Wakatsuki; Derry C Roopenian; Atsushi Mizoguchi; Wayne I Lencer; Richard S Blumberg
Journal:  J Clin Invest       Date:  2006-08       Impact factor: 14.808

Review 2.  Citrobacter rodentium of mice and man.

Authors:  Rosanna Mundy; Thomas T MacDonald; Gordon Dougan; Gad Frankel; Siouxsie Wiles
Journal:  Cell Microbiol       Date:  2005-12       Impact factor: 3.715

3.  Transforming growth factor-beta induces development of the T(H)17 lineage.

Authors:  Paul R Mangan; Laurie E Harrington; Darrell B O'Quinn; Whitney S Helms; Daniel C Bullard; Charles O Elson; Robin D Hatton; Sharon M Wahl; Trenton R Schoeb; Casey T Weaver
Journal:  Nature       Date:  2006-04-30       Impact factor: 49.962

4.  Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease.

Authors:  Marc Veldhoen; Richard J Hocking; Richard A Flavell; Brigitta Stockinger
Journal:  Nat Immunol       Date:  2006-09-24       Impact factor: 25.606

5.  Mast cells limit systemic bacterial dissemination but not colitis in response to Citrobacter rodentium.

Authors:  Olivia L Wei; Ashley Hilliard; Daniel Kalman; Melanie Sherman
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

6.  Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses.

Authors:  Harumichi Ishigame; Shigeru Kakuta; Takeshi Nagai; Motohiko Kadoki; Aya Nambu; Yutaka Komiyama; Noriyuki Fujikado; Yuko Tanahashi; Aoi Akitsu; Hayato Kotaki; Katsuko Sudo; Susumu Nakae; Chihiro Sasakawa; Yoichiro Iwakura
Journal:  Immunity       Date:  2009-01-16       Impact factor: 31.745

7.  Stimulation of the intracellular bacterial sensor NOD2 programs dendritic cells to promote interleukin-17 production in human memory T cells.

Authors:  Astrid J van Beelen; Zuzana Zelinkova; Esther W Taanman-Kueter; Femke J Muller; Daniel W Hommes; Sebastian A J Zaat; Martien L Kapsenberg; Esther C de Jong
Journal:  Immunity       Date:  2007-10-04       Impact factor: 31.745

8.  Fcgamma receptor regulation of Citrobacter rodentium infection.

Authors:  Atsuhiro Masuda; Masaru Yoshida; Hideyuki Shiomi; Satoshi Ikezawa; Tetsuya Takagawa; Hiroshi Tanaka; Ryo Chinzei; Tsukasa Ishida; Yoshinori Morita; Hiromu Kutsumi; Hideto Inokuchi; Shuo Wang; Kanna Kobayashi; Shigeto Mizuno; Akira Nakamura; Toshiyuki Takai; Richard S Blumberg; Takeshi Azuma
Journal:  Infect Immun       Date:  2008-01-28       Impact factor: 3.441

9.  Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens.

Authors:  Yan Zheng; Patricia A Valdez; Dimitry M Danilenko; Yan Hu; Susan M Sa; Qian Gong; Alexander R Abbas; Zora Modrusan; Nico Ghilardi; Frederic J de Sauvage; Wenjun Ouyang
Journal:  Nat Med       Date:  2008-02-10       Impact factor: 53.440

10.  Syk- and CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17.

Authors:  Salomé LeibundGut-Landmann; Olaf Gross; Matthew J Robinson; Fabiola Osorio; Emma C Slack; S Vicky Tsoni; Edina Schweighoffer; Victor Tybulewicz; Gordon D Brown; Jürgen Ruland; Caetano Reis e Sousa
Journal:  Nat Immunol       Date:  2007-04-22       Impact factor: 25.606

View more
  35 in total

1.  Targeting cellular fatty acid synthesis limits T helper and innate lymphoid cell function during intestinal inflammation and infection.

Authors:  Panagiota Mamareli; Friederike Kruse; Chia-Wen Lu; Melanie Guderian; Stefan Floess; Katharina Rox; David S J Allan; James R Carlyle; Mark Brönstrup; Rolf Müller; Luciana Berod; Tim Sparwasser; Matthias Lochner
Journal:  Mucosal Immunol       Date:  2020-04-30       Impact factor: 7.313

Review 2.  Citrobacter rodentium: a model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity.

Authors:  D J Silberger; C L Zindl; C T Weaver
Journal:  Mucosal Immunol       Date:  2017-06-14       Impact factor: 7.313

3.  Attenuation of intestinal inflammation in interleukin-10-deficient mice infected with Citrobacter rodentium.

Authors:  Sara M Dann; Christine Le; Barun K Choudhury; Houpu Liu; Omar Saldarriaga; Elaine M Hanson; Yingzi Cong; Lars Eckmann
Journal:  Infect Immun       Date:  2014-02-24       Impact factor: 3.441

4.  Epithelial Histone Deacetylase 3 Instructs Intestinal Immunity by Coordinating Local Lymphocyte Activation.

Authors:  Nazanin Navabi; Jordan Whitt; Shu-En Wu; Vivienne Woo; Jessica Moncivaiz; Michael B Jordan; Bruce A Vallance; Sing Sing Way; Theresa Alenghat
Journal:  Cell Rep       Date:  2017-05-09       Impact factor: 9.423

5.  The sphingosine-1-phosphate analogue FTY720 impairs mucosal immunity and clearance of the enteric pathogen Citrobacter rodentium.

Authors:  Carola T Murphy; Lindsay J Hall; Grainne Hurley; Aoife Quinlan; John MacSharry; Fergus Shanahan; Kenneth Nally; Silvia Melgar
Journal:  Infect Immun       Date:  2012-05-21       Impact factor: 3.441

6.  Active vitamin D (1,25-dihydroxyvitamin D3) increases host susceptibility to Citrobacter rodentium by suppressing mucosal Th17 responses.

Authors:  Natasha R Ryz; Scott J Patterson; Yiqun Zhang; Caixia Ma; Tina Huang; Ganive Bhinder; Xiujuan Wu; Justin Chan; Alexa Glesby; Ho Pan Sham; Jan P Dutz; Megan K Levings; Kevan Jacobson; Bruce A Vallance
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-09-27       Impact factor: 4.052

Review 7.  T cells and intestinal commensal bacteria--ignorance, rejection, and acceptance.

Authors:  Jiani N Chai; You W Zhou; Chyi-Song Hsieh
Journal:  FEBS Lett       Date:  2014-07-02       Impact factor: 4.124

8.  Resistin-like molecule α promotes pathogenic Th17 cell responses and bacterial-induced intestinal inflammation.

Authors:  Lisa C Osborne; Karen L Joyce; Theresa Alenghat; Gregory F Sonnenberg; Paul R Giacomin; Yurong Du; Kirk S Bergstrom; Bruce A Vallance; Meera G Nair
Journal:  J Immunol       Date:  2013-01-25       Impact factor: 5.422

9.  Dietary vitamin D3 deficiency alters intestinal mucosal defense and increases susceptibility to Citrobacter rodentium-induced colitis.

Authors:  Natasha R Ryz; Arion Lochner; Kirandeep Bhullar; Caixia Ma; Tina Huang; Ganive Bhinder; Else Bosman; Xiujuan Wu; Sheila M Innis; Kevan Jacobson; Bruce A Vallance
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-09-03       Impact factor: 4.052

Review 10.  Uncovering the role of the gut microbiota in immune checkpoint blockade therapy: A mini-review.

Authors:  Taylor Halsey; Gabriel Ologun; Jennifer Wargo; Robert R Jenq
Journal:  Semin Hematol       Date:  2020-05-19       Impact factor: 3.851

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.